Multiple C-Suite Executives Sell Over $35M in Shares to Company Buyback Program

summarizeSummary

Stagwell Inc. disclosed that its CEO and other C-suite executives sold over $35 million in shares to the company's buyback program, alongside discretionary vesting of executive equity awards despite missed performance targets.

check_boxKey Events

• Significant Executive Share Sales

  The company repurchased shares totaling $35,040,011 from multiple C-suite executives on March 11, 2026, at $6.1677 per share. This included $28,200,001 from CEO Mark Penn, $4,100,003 from President Jay Leveton, and $2,490,005 from CFO Ryan Greene.

• Discretionary LTIP Vesting Despite Missed Targets

  The Human Resources and Compensation Committee discretionarily vested 91% of 2023 Stock LTIP awards and 82% of 2022 Stock LTIP awards, despite the company not meeting the minimum Adjusted EBITDA targets for those periods.

• Executive Compensation Adjustments

  For 2025, 2024, and 2023, annual cash incentives were not paid due to missed Adjusted EBITDA targets, with executives instead receiving additional equity incentives (restricted stock units).

• Late Section 16(a) Filings Noted

  The filing disclosed several delinquent Section 16(a) reports in 2025 from directors Eli Samaha, Brandt Vaughan, Desirée Rogers, and significant stockholders Steven A. Ballmer and Polpat LLC.

auto_awesomeAnalysis

Stagwell Inc.'s definitive proxy statement reveals that several C-suite executives, including CEO Mark Penn, sold a substantial amount of shares back to the company as part of its share repurchase program. This collective reduction in executive ownership, totaling over $35 million, represents a significant liquidity event for these insiders. While the company's share buyback program is generally a positive signal, the executives' decision to sell into it indicates a reduction in their personal stake. Additionally, the Human Resources and Compensation Committee discretionarily vested a large portion of performance-based long-term incentive awards despite the company not meeting its Adjusted EBITDA targets for two consecutive years, raising questions about strict pay-for-performance alignment. The filing also notes several delinquent Section 16(a) reports from insiders, indicating compliance lapses.